World · India Bureau
Hospital cancer drug costs exceed pharmacy prices, Max Healthcare CMD says
Max Healthcare's commanding officer has clarified that hospital medicine pricing reflects multiple cost components beyond the drug itself. The explanation addresses growing consumer concerns over significant price disparities for cancer treatments between retail pharmacies and hospital dispensaries.
LSN India ·
Hospital prices for cancer medications often substantially exceed those charged by retail pharmacies, but the difference reflects broader operational factors rather than markup on drugs alone, according to Abhay Soi, CMD of Max Healthcare.
When hospitals dispense medicines, the final cost to patients encompasses multiple elements beyond the pharmaceutical product's base price. These include infrastructure expenses, staff costs, storage and handling requirements, regulatory compliance, and ancillary services provided during hospital treatment.
Cancer drugs particularly attract scrutiny given their high unit costs and critical importance to patient outcomes. The pricing structure at healthcare facilities differs fundamentally from retail pharmacy models, which typically operate with lower overhead and narrower service provision.
The clarification addresses longstanding consumer complaints about cost variations across different dispensing channels. Industry observers note that patients often face difficult decisions when comparing treatment options at hospitals versus purchasing medications independently, particularly for expensive oncology treatments where cumulative costs can be substantial.
As healthcare costs remain a contentious issue across India, hospitals and pharmacy operators continue facing pressure to improve pricing transparency and justify cost differentials to patients and policymakers alike.